Pharmaceutical compositions

Details for Australian Patent Application No. 2002324026 (hide)

Owner Mitsubishi Pharma Corporation

Inventors Fujii, Tsuneo; Masuda, Rumiko; Sakai, Atsushi; Chiba, Kenji; Mishina, Tadashi

Agent Griffith Hack

Pub. Number AU-B-2002324026

Parent 18911

Filing date 31 December 2002

Wipo publication date 3 April 2003

Acceptance publication date 14 July 2005

International Classifications

A61K 031/135 - having aromatic rings, e.g. methadone

A61K 047/40 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

Event Publications

16 January 2003 Complete Application Filed

3 April 2003 Application Open to Public Inspection

  Published as AU-B-2002324026

14 July 2005 Application Accepted

  Published as AU-B-2002324026

10 November 2005 Standard Patent Sealed

11 June 2009 Assignment Registered

  Mitsubishi Pharma Corporation The patent has been assigned to Novartis AG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002324027-Electromagnetic resistivity instrument having look ahead capability

2002324025-Color separation method and printed product of the method